1 |
0.15mg kpg-818 dose |
- |
- |
- |
- |
049 1件: 49 💬 |
2 |
0.6mg kpg-818 dose |
- |
- |
- |
- |
049 1件: 49 💬 |
3 |
1 mg/kg cnto 136 |
- |
- |
- |
- |
049 1件: 49 💬 |
4 |
10 mg/kg cnto 136 |
- |
- |
- |
- |
049 1件: 49 💬 |
5 |
2-deoxy-2 [f-18] fluoro-2-d-glucose |
D-glucose |
1件: D00009 D00009 💬 |
- |
- |
049 1件: 49 💬 |
6 |
2mg kpg-818 dose |
- |
- |
- |
- |
049 1件: 49 💬 |
7 |
4 mg/kg cnto 136 |
- |
- |
- |
- |
049 1件: 49 💬 |
8 |
81mg aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 1件: 49 💬 |
9 |
A-623 |
- |
- |
- |
- |
049 1件: 49 💬 |
10 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
11 |
Abbv-105 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
12 |
Abetimus |
Abetimus |
- |
- |
- |
049 1件: 49 💬 |
13 |
Abetimus sodium |
Abetimus |
- |
- |
- |
049 1件: 49 💬 |
14 |
Abetimus sodium (ljp 394) |
Abetimus |
- |
- |
- |
049 1件: 49 💬 |
15 |
Abr-215757 |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
16 |
Abt-199 |
- |
- |
- |
- |
049 1件: 49 💬 |
17 |
Abt-494 |
- |
- |
- |
- |
041 6件: 41, 46, 49, 96, 97, 271 💬 |
18 |
Ac0058ta |
- |
- |
- |
- |
049 1件: 49 💬 |
19 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
20 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
21 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
22 |
Acido micofenolico |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 1件: 49 💬 |
23 |
Acm |
- |
- |
- |
- |
049 1件: 49 💬 |
24 |
Act-334441 |
- |
- |
- |
- |
049 1件: 49 💬 |
25 |
Acthar |
- |
- |
- |
- |
002 9件: 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
26 |
Acthar gel |
- |
- |
- |
- |
013 6件: 13, 46, 49, 50, 84, 222 💬 |
27 |
Acthar high dose (80 u) |
- |
- |
- |
- |
049 1件: 49 💬 |
28 |
Acthar low dose (40 u) |
- |
- |
- |
- |
049 1件: 49 💬 |
29 |
Ags-009 |
- |
- |
- |
- |
049 1件: 49 💬 |
30 |
Aidsvax® b/e |
- |
- |
- |
- |
049 1件: 49 💬 |
31 |
Akbm-3031 |
- |
- |
- |
- |
049 1件: 49 💬 |
32 |
Aldesleuchina |
- |
- |
- |
- |
049 1件: 49 💬 |
33 |
Aldesleukin |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 4件: 49, 65, 96, 97 💬 |
34 |
Alfacalcidol |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 6件: 41, 46, 49, 50, 96, 235 💬 |
35 |
Alitretinoin |
Alitretinoin |
1件: D02815 D02815 💬 |
RARA 5件: RARA, RARB, RXRA, RXRB, RXRG 💬 |
Acute myeloid leukemia 17件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
049 1件: 49 💬 |
36 |
Allogeneic bone marrow transplant |
- |
- |
- |
- |
049 1件: 49 💬 |
37 |
Allogeneic mesenchymal stromal cells derived from the umbilical cord |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
049 1件: 49 💬 |
38 |
Allogeneic msc (allomsc) |
- |
- |
- |
- |
049 1件: 49 💬 |
39 |
Allogeneic stem cell transplantation |
- |
- |
- |
- |
049 2件: 49, 84 💬 |
40 |
Alpha-tocopherol |
Tocopherol |
2件: D02331 D02331, D02332 D02332 💬 |
- |
- |
049 2件: 49, 206 💬 |
41 |
Alx-0061 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
42 |
Alx-0061 150 mg/ml |
- |
- |
- |
- |
049 1件: 49 💬 |
43 |
Amg 557 |
- |
- |
- |
- |
049 1件: 49 💬 |
44 |
Amg 570 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
45 |
Amg 592 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
46 |
Amg 623 |
- |
- |
- |
- |
049 1件: 49 💬 |
47 |
Amg 811 |
- |
- |
- |
- |
049 1件: 49 💬 |
48 |
Amg592 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
49 |
Amg811 |
- |
- |
- |
- |
049 1件: 49 💬 |
50 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
51 |
Anifrolumab |
Anifrolumab |
1件: D11082 D11082 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
046 2件: 46, 49 💬 |
52 |
Anifrolumab 1000 mg |
Anifrolumab |
1件: D11082 D11082 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
049 1件: 49 💬 |
53 |
Anifrolumab 300 mg |
Anifrolumab |
1件: D11082 D11082 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
049 1件: 49 💬 |
54 |
Anti baff (b cell activating factor) |
- |
- |
- |
- |
049 1件: 49 💬 |
55 |
Anti lp40 antibody, subclass igg4 |
- |
- |
- |
- |
049 1件: 49 💬 |
56 |
Anti lp40 anticuerpo, subclase igg4 |
- |
- |
- |
- |
049 1件: 49 💬 |
57 |
Anti-blood dendritic cell antigen 2 |
- |
- |
- |
- |
049 1件: 49 💬 |
58 |
Anti-cd19-car-t cells |
- |
- |
- |
- |
049 1件: 49 💬 |
59 |
Anti-cd20 b cell depletion with truxima |
- |
- |
- |
- |
049 1件: 49 💬 |
60 |
Anti-cd28dab |
- |
- |
- |
- |
049 3件: 49, 53, 160 💬 |
61 |
Anti-macrophage migration inhibitory factor (anti-mif) antibody |
- |
- |
- |
- |
049 1件: 49 💬 |
62 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 5件: 46, 49, 50, 51, 53 💬 |
63 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
64 |
Asf-1096 cream 0.25% |
- |
- |
- |
- |
049 1件: 49 💬 |
65 |
Asf-1096 cream 0.5% |
- |
- |
- |
- |
049 1件: 49 💬 |
66 |
Asf-1096 cream 1.0% |
- |
- |
- |
- |
049 1件: 49 💬 |
67 |
Aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
68 |
Aspirin and meloxicam |
Acetylsalicylic acid |
2件: D00109 D00109, D00969 D00969 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 1件: 49 💬 |
69 |
Atacicept |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 49, 66 💬 |
70 |
Atacicept 150 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 2件: 13, 49 💬 |
71 |
Atacicept 75 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 49, 66 💬 |
72 |
Atacicept 75 milligram (mg) |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
73 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
74 |
Autologous ebv specific ctl infusion |
- |
- |
- |
- |
049 1件: 49 💬 |
75 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 4件: 49, 51, 85, 86 💬 |
76 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
77 |
Baricitinib |
Baricitinib |
1件: D10308 D10308 💬 |
JAK1 2件: JAK1, JAK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 33件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
041 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 |
78 |
Behavioral: heart health educational program |
- |
- |
- |
- |
049 1件: 49 💬 |
79 |
Behavioral: questionnaires |
- |
- |
- |
- |
028 2件: 28, 49 💬 |
80 |
Belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
81 |
Belimumab 1 mg/kg |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 2件: 46, 49 💬 |
82 |
Belimumab 10 mg/kg |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
043 3件: 43, 46, 49 💬 |
83 |
Belimumab 10 mg/kg plus standard therapy |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
84 |
Belimumab 100 mg sc |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
85 |
Belimumab 10mg/kg |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
86 |
Belimumab 200 mg sc |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
87 |
Belimumab 200 mg/ml |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
88 |
Belimumab 4 mg/kg |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 2件: 46, 49 💬 |
89 |
Belimumab for iv |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
90 |
Belimumab for sc |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
91 |
Belimumab injection |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
92 |
Belimumab injection [benlysta] |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
93 |
Belimumab or benlysta |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
94 |
Belimumab plus early vaccination |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
95 |
Belimumab plus late vaccination |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
96 |
Benazepril |
Benazepril |
2件: D00620 D00620, D07499 D07499 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 4件: 49, 57, 218, 224 💬 |
97 |
Benazepril pill |
Benazepril |
2件: D00620 D00620, D07499 D07499 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 1件: 49 💬 |
98 |
Benlysta |
- |
- |
- |
- |
043 5件: 43, 49, 53, 66, 222 💬 |
99 |
Benlysta (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 4件: 11, 49, 53, 222 💬 |
100 |
Benlysta 400 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
043 2件: 43, 49 💬 |
101 |
Benlysta 400 mg powder for concentrate for solution for infusions |
- |
- |
- |
- |
049 1件: 49 💬 |
102 |
Benlysta? (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
103 |
Benlysta® |
- |
- |
- |
- |
049 2件: 49, 222 💬 |
104 |
Benlysta™ (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
105 |
Bi 705564 |
- |
- |
- |
- |
049 1件: 49 💬 |
106 |
Biib059 |
- |
- |
- |
- |
049 1件: 49 💬 |
107 |
Blisibimod |
Blisibimod |
1件: D10311 D10311 💬 |
- |
- |
043 5件: 43, 44, 49, 63, 66 💬 |
108 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
109 |
Bms-188667 |
- |
- |
- |
- |
046 8件: 46, 49, 53, 65, 96, 97, 222, 271 💬 |
110 |
Bms-931699 |
Lulizumab pegol |
- |
- |
- |
049 3件: 49, 53, 160 💬 |
111 |
Bms-986165 |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
112 |
Bms-986165 capsule |
- |
- |
- |
- |
049 1件: 49 💬 |
113 |
Bms-986165 tablet |
- |
- |
- |
- |
049 1件: 49 💬 |
114 |
Bms-986195 |
Branebrutinib |
1件: D11478 D11478 💬 |
BTK 1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 3件: 46, 49, 53 💬 |
115 |
Bms986195 |
- |
- |
- |
- |
046 3件: 46, 49, 53 💬 |
116 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
117 |
Bos161721 |
- |
- |
- |
- |
049 1件: 49 💬 |
118 |
Br-dim |
- |
- |
- |
- |
049 1件: 49 💬 |
119 |
Branebrutinib |
Branebrutinib |
1件: D11478 D11478 💬 |
BTK 1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 3件: 46, 49, 53 💬 |
120 |
Brentuximab |
Brentuximab vedotin |
1件: D09587 D09587 💬 |
TNFRSF8 10件: TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 11件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 2件: 49, 51 💬 |
121 |
Brentuximab vedotin |
Brentuximab vedotin |
1件: D09587 D09587 💬 |
TNFRSF8 10件: TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 11件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 2件: 49, 51 💬 |
122 |
Bt063 |
- |
- |
- |
- |
049 1件: 49 💬 |
123 |
Busulfan |
Busulfan |
1件: D00248 D00248 💬 |
- |
- |
019 13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
124 |
Calcitriol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
125 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
126 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
127 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
128 |
Cc-220 |
CC-220 |
- |
- |
- |
049 2件: 49, 84 💬 |
129 |
Cdp3194 |
- |
- |
- |
- |
049 1件: 49 💬 |
130 |
Cdp7657 |
- |
- |
- |
- |
049 1件: 49 💬 |
131 |
Cellcept |
- |
- |
- |
- |
011 5件: 11, 13, 42, 43, 49 💬 |
132 |
Cenerimod |
Cenerimod |
1件: D11283 D11283 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 1件: 49 💬 |
133 |
Cenerimod 0.5 mg |
Cenerimod |
1件: D11283 D11283 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 1件: 49 💬 |
134 |
Cenerimod 1 mg |
Cenerimod |
1件: D11283 D11283 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 1件: 49 💬 |
135 |
Cenerimod 2 mg |
Cenerimod |
1件: D11283 D11283 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 1件: 49 💬 |
136 |
Cenerimod 4 mg |
Cenerimod |
1件: D11283 D11283 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 1件: 49 💬 |
137 |
Cep-33457 |
- |
- |
- |
- |
049 1件: 49 💬 |
138 |
Cervarix |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
139 |
Cervarix suspensie voor injectie |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
140 |
Cfz533 |
- |
- |
- |
- |
011 4件: 11, 46, 49, 53 💬 |
141 |
Chloroquine |
Chloroquine |
3件: D02125 D02125, D02366 D02366, D03469 D03469 💬 |
- |
- |
046 3件: 46, 49, 95 💬 |
142 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
143 |
Cholecalciferol and c. xanthorrhiza |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 1件: 49 💬 |
144 |
Ciclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
145 |
Ciclosporina |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
049 3件: 49, 97, 228 💬 |
146 |
Clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
147 |
Clopidogrel |
Clopidogrel |
4件: D00769 D00769, D07729 D07729, D10823 D10823, D10824 D10824 💬 |
P2RY12 1件: P2RY12 💬 |
Platelet activation 1件: Platelet activation |
049 2件: 49, 86 💬 |
148 |
Cnto1275 |
- |
- |
- |
- |
046 6件: 46, 49, 84, 93, 96, 97 💬 |
149 |
Combination product: belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
150 |
Conjugated equine estrogens |
Conjugated estrogens |
2件: D04070 D04070, D05987 D05987 💬 |
- |
- |
049 1件: 49 💬 |
151 |
Conjugated equine estrogens 0.625 mg/d + mpa 5 mg/d/10d |
Conjugated estrogens |
2件: D04070 D04070, D05987 D05987 💬 |
- |
- |
049 1件: 49 💬 |
152 |
Continuation of azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
049 1件: 49 💬 |
153 |
Corn starch |
Starch, corn |
1件: D05297 D05297 💬 |
- |
- |
049 1件: 49 💬 |
154 |
Corticosteroids |
- |
- |
- |
- |
041 10件: 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
155 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
9件: D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
156 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
157 |
Crestor |
- |
- |
- |
- |
049 3件: 49, 79, 299 💬 |
158 |
Csa |
- |
- |
- |
- |
019 8件: 19, 49, 50, 53, 60, 63, 222, 228 💬 |
159 |
Csm allogéniques issues de cordons ombilicaux ( mti-pp) |
- |
- |
- |
- |
049 1件: 49 💬 |
160 |
Ctla4-igg4m (rg2077) |
- |
- |
- |
- |
049 1件: 49 💬 |
161 |
Ctla4ig |
- |
- |
- |
- |
046 4件: 46, 49, 96, 271 💬 |
162 |
Cumulative corticosteroid exposure |
- |
- |
- |
- |
049 1件: 49 💬 |
163 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
164 |
Curcumin supplement |
Curcumin |
- |
- |
- |
049 1件: 49 💬 |
165 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
166 |
Cyclophosphamide-prednisone-azathioprine |
Azathioprine |
5件: D00238 D00238, D00287 D00287, D00473 D00473, D03033 D03033, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
167 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
168 |
Cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
169 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
170 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
171 |
Cymbalta |
- |
- |
- |
- |
006 3件: 6 , 13, 49 💬 |
172 |
Cytarabine |
Cytarabine |
3件: D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 6件: 11, 13, 14, 25, 49, 60 💬 |
173 |
D-glucose |
D-glucose |
1件: D00009 D00009 💬 |
- |
- |
049 3件: 49, 86, 88 💬 |
174 |
Dapagliflozin |
Dapagliflozin |
1件: D08897 D08897 💬 |
- |
- |
049 2件: 49, 222 💬 |
175 |
Dapirolizumab pegol |
Dapirolizumab pegol |
- |
- |
- |
013 2件: 13, 49 💬 |
176 |
Dapirolizumab pegol (dzp) |
Dapirolizumab pegol |
- |
- |
- |
049 1件: 49 💬 |
177 |
Dehydroepiandrosterone |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 5件: 49, 53, 83, 96, 113 💬 |
178 |
Dehydroepiandrosterone (dhea) |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 1件: 49 💬 |
179 |
Deltacortene*20cpr 5mg |
- |
- |
- |
- |
049 3件: 49, 97, 113 💬 |
180 |
Device: belimumab autoinjector |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
181 |
Device: bone densitometry |
- |
- |
- |
- |
049 1件: 49 💬 |
182 |
Device: doppler ultrasound |
- |
- |
- |
- |
049 1件: 49 💬 |
183 |
Device: fan beam ct scan |
- |
- |
- |
- |
049 1件: 49 💬 |
184 |
Device: flash glucose monitoring system |
Dextrose, unspecified form |
- |
- |
- |
049 1件: 49 💬 |
185 |
Device: flow-mediated dilation of the brachial artery |
- |
- |
- |
- |
049 1件: 49 💬 |
186 |
Dha |
- |
- |
- |
- |
006 8件: 6 , 46, 48, 49, 94, 113, 299, 301 💬 |
187 |
Dhea |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 3件: 49, 86, 96 💬 |
188 |
Dihydroartemisinin |
Artenimol |
1件: D07362 D07362 💬 |
- |
- |
049 1件: 49 💬 |
189 |
Dihydroartemisinin tablet |
Artenimol |
1件: D07362 D07362 💬 |
- |
- |
049 1件: 49 💬 |
190 |
Dimethylfumarat |
- |
- |
- |
- |
049 1件: 49 💬 |
191 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
192 |
Dipyridamole |
Dipyridamole |
1件: D00302 D00302 💬 |
PDE4A 2件: PDE4A, PDE5A 💬 |
Metabolic pathways 6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 5件: 46, 49, 51, 66, 224 💬 |
193 |
Docosahexaenoic acid |
Doconexent |
- |
- |
- |
006 7件: 6 , 49, 90, 94, 240, 299, 301 💬 |
194 |
Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
195 |
Dzp |
- |
- |
- |
- |
049 1件: 49 💬 |
196 |
Edratide |
Edratide |
1件: D03957 D03957 💬 |
- |
- |
049 1件: 49 💬 |
197 |
Edratide acetate |
Acetate |
1件: D03957 D03957 💬 |
- |
- |
049 1件: 49 💬 |
198 |
Eicosapentaenoic acid |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
049 5件: 49, 96, 97, 296, 297 💬 |
199 |
Elsubrutinib |
- |
- |
- |
- |
049 1件: 49 💬 |
200 |
Enteric-coated mycophenolate sodium |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 1件: 49 💬 |
201 |
Epa |
- |
- |
- |
- |
008 6件: 8 , 46, 48, 49, 113, 301 💬 |
202 |
Epa and dha supplementation |
- |
- |
- |
- |
048 2件: 48, 49 💬 |
203 |
Epatuzumab |
- |
- |
- |
- |
049 1件: 49 💬 |
204 |
Epratuzumab |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
205 |
Epratuzumab 100 mg |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
206 |
Epratuzumab 1200 mg |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
207 |
Epratuzumab 400 mg |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
208 |
Epratuzumab 600 mg |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
209 |
Epratuzumab iv |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
210 |
Epratuzumab sc |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
211 |
Erl080a |
- |
- |
- |
- |
049 1件: 49 💬 |
212 |
Estradiol |
Estradiol |
8件: D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 5件: 13, 46, 49, 226, 299 💬 |
213 |
Ethinyl estradiol |
Estradiol |
9件: D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 3件: 46, 49, 299 💬 |
214 |
Ethylhydrogenfumarat, calciumsalz |
- |
- |
- |
- |
049 1件: 49 💬 |
215 |
Ethylhydrogenfumarat, magnesiumsalz |
- |
- |
- |
- |
049 1件: 49 💬 |
216 |
Ethylhydrogenfumarat, zinksalz |
- |
- |
- |
- |
049 1件: 49 💬 |
217 |
Evobrutinib |
Evobrutinib |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
218 |
Extended release dipyridamole 200mg/aspirin 25mg |
Acetylsalicylic acid |
2件: D00109 D00109, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, PTGS1, PTGS2 💬 |
Alzheimer disease 28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
219 |
Ezetimibe |
Ezetimibe |
1件: D01966 D01966 💬 |
NPC1L1 1件: NPC1L1 💬 |
Fat digestion and absorption 1件: Fat digestion and absorption |
049 4件: 49, 79, 93, 260 💬 |
220 |
Ezetimibe+simvastatin drug combination |
Ezetimibe |
2件: D00434 D00434, D01966 D01966 💬 |
HMGCR 2件: HMGCR, NPC1L1 💬 |
AMPK signaling pathway 5件: AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Metabolic pathways, Terpenoid backbone biosynthesis |
049 1件: 49 💬 |
221 |
Faslodex |
- |
- |
- |
- |
049 1件: 49 💬 |
222 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
223 |
Fish oil |
Fish oil |
- |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
224 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
225 |
Fludarabine phosphate |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
226 |
Fluzone |
- |
- |
- |
- |
021 2件: 21, 49 💬 |
227 |
Focetria (monovalent mf59-adjuvanted vaccine) |
- |
- |
- |
- |
046 3件: 46, 49, 271 💬 |
228 |
Folate |
Folic acid |
1件: D00070 D00070 💬 |
- |
- |
013 3件: 13, 46, 49 💬 |
229 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 4件: 13, 46, 49, 96 💬 |
230 |
Folic acid |
Folic acid |
1件: D00070 D00070 💬 |
- |
- |
006 4件: 6 , 46, 49, 84 💬 |
231 |
Forigerimod |
Forigerimod |
1件: D09904 D09904 💬 |
- |
- |
049 1件: 49 💬 |
232 |
Fostamatinib |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 4件: 46, 49, 61, 66 💬 |
233 |
Fostamatinib disodium (r935788) |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 2件: 46, 49 💬 |
234 |
Fumaderm® |
- |
- |
- |
- |
049 1件: 49 💬 |
235 |
Fumaderm® initial |
- |
- |
- |
- |
049 1件: 49 💬 |
236 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
237 |
Gardasil |
- |
- |
- |
- |
049 1件: 49 💬 |
238 |
Gc+hcq |
- |
- |
- |
- |
049 1件: 49 💬 |
239 |
Gdc-0853 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
240 |
Gdc-0853 ro7010939 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
241 |
Genetic: polymorphism analysis |
- |
- |
- |
- |
049 2件: 49, 60 💬 |
242 |
Gl701 |
- |
- |
- |
- |
049 1件: 49 💬 |
243 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
244 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
245 |
Group a sle prospective study |
- |
- |
- |
- |
049 1件: 49 💬 |
246 |
Growth colony stimulating factor (g-csf) |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
049 1件: 49 💬 |
247 |
Gsk1550188 |
- |
- |
- |
- |
011 4件: 11, 49, 66, 222 💬 |
248 |
Gsk1550188 1mg/kg or 10mg/kg |
- |
- |
- |
- |
049 1件: 49 💬 |
249 |
Gsk1550188 iv |
- |
- |
- |
- |
049 1件: 49 💬 |
250 |
Gsk1550188 sc |
- |
- |
- |
- |
049 1件: 49 💬 |
251 |
Gsk2586184 |
- |
- |
- |
- |
049 1件: 49 💬 |
252 |
Gsk2586184 100 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
253 |
Gsk2586184 200 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
254 |
Gsk2586184 400 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
255 |
Gsk2586184 50 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
256 |
Gsk2586184 800mg single and repeat dose |
- |
- |
- |
- |
049 1件: 49 💬 |
257 |
Gsk2586184 new formulation |
- |
- |
- |
- |
049 1件: 49 💬 |
258 |
Gsk2586184 standard formulation |
- |
- |
- |
- |
049 1件: 49 💬 |
259 |
H.p. acthar gel |
- |
- |
- |
- |
046 5件: 46, 49, 50, 84, 222 💬 |
260 |
Hcq |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
261 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
262 |
Hgs1006 |
- |
- |
- |
- |
049 1件: 49 💬 |
263 |
Hgs1006, lymphostat-b, monoclonal anti-blys, lsb, benlysta |
- |
- |
- |
- |
049 2件: 49, 53 💬 |
264 |
High dietary sodium |
- |
- |
- |
- |
049 1件: 49 💬 |
265 |
High dose mesenchymal stem cells (mscs) |
- |
- |
- |
- |
049 1件: 49 💬 |
266 |
Hiomega-3 supplement of naturalis® company - |
- |
- |
- |
- |
049 1件: 49 💬 |
267 |
Hll2 |
- |
- |
- |
- |
049 1件: 49 💬 |
268 |
Hll2 (epratuzumab) |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
269 |
Hll2 (trivial name or chemical description) |
- |
- |
- |
- |
049 1件: 49 💬 |
270 |
Hll2,immu-103 |
- |
- |
- |
- |
049 1件: 49 💬 |
271 |
Hpv prophylactic vaccine gardasil |
- |
- |
- |
- |
049 1件: 49 💬 |
272 |
Hril-2 active |
- |
- |
- |
- |
046 3件: 46, 49, 53 💬 |
273 |
Human papillomavirus vaccination (gardasil) |
- |
- |
- |
- |
049 1件: 49 💬 |
274 |
Human umbilical cord derived msc transplantation for sle |
- |
- |
- |
- |
049 1件: 49 💬 |
275 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
276 |
Hydroxychloroquine (z0188) |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
277 |
Hydroxychloroquine high |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
278 |
Hydroxychloroquine or chloroquine |
Chloroquine |
4件: D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
279 |
Hydroxychloroquine reduced |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
280 |
Ianalumab |
- |
- |
- |
- |
035 5件: 35, 46, 49, 53, 95 💬 |
281 |
Ibandronate |
Ibandronate |
1件: D08056 D08056 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 2件: 46, 49 💬 |
282 |
Ibandronate+alfacalcidol+calcium |
Alfacalcidol |
2件: D01518 D01518, D08056 D08056 💬 |
FDPS 2件: FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 8件: Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
049 1件: 49 💬 |
283 |
Ici 182,780 (faslodex) |
- |
- |
- |
- |
049 1件: 49 💬 |
284 |
Icp-022 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
285 |
Ifn-a 2b kinoid drug substance |
- |
- |
- |
- |
049 1件: 49 💬 |
286 |
Ifn-a2b kinoid |
- |
- |
- |
- |
049 1件: 49 💬 |
287 |
Ifn-k |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
288 |
Ifn-kinoid |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
289 |
Ifn-kinoid drug substance |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
290 |
Ifna-kinoid |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
291 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 6件: 2 , 46, 49, 53, 56, 96 💬 |
292 |
Il-6r nanobody |
- |
- |
- |
- |
049 1件: 49 💬 |
293 |
Ilt-101 |
- |
- |
- |
- |
049 1件: 49 💬 |
294 |
Immu-103 |
- |
- |
- |
- |
049 1件: 49 💬 |
295 |
Immune ablation and hematopoietic stem cell support. |
- |
- |
- |
- |
049 1件: 49 💬 |
296 |
Immunoglobulin g |
- |
- |
- |
- |
011 7件: 11, 13, 14, 49, 50, 63, 65 💬 |
297 |
Immunoglobulin g1, anti-(human type i interferon receptor) (human monoclonal medi-546 heavy chain), disulfide with human monoclonal medi-546-chain, dimer |
- |
- |
- |
- |
049 1件: 49 💬 |
298 |
Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) |
Azathioprine |
8件: D00142 D00142, D00238 D00238, D00752 D00752, D02115 D02115, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
DHFR 4件: DHFR, DHFR2, IMPDH1, IMPDH2 💬 |
Antifolate resistance 7件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism |
049 1件: 49 💬 |
299 |
Individualized dose of rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
049 1件: 49 💬 |
300 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
301 |
Influenz virus surface antigens |
- |
- |
- |
- |
049 1件: 49 💬 |
302 |
Influenza vaccine (surface antigen, inactivated) |
- |
- |
- |
- |
049 1件: 49 💬 |
303 |
Influvac |
- |
- |
- |
- |
046 3件: 46, 49, 50 💬 |
304 |
Interleukin 2 |
- |
- |
- |
- |
046 9件: 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
305 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 8件: 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
306 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 8件: 13, 14, 35, 38, 39, 49, 51, 309 💬 |
307 |
Ipp - 201101 |
- |
- |
- |
- |
049 1件: 49 💬 |
308 |
Ipp-201101 |
- |
- |
- |
- |
049 1件: 49 💬 |
309 |
Ipp-201101, p140 |
- |
- |
- |
- |
049 1件: 49 💬 |
310 |
Iscalimab |
Iscalimab |
1件: D11610 D11610 💬 |
CD40 1件: CD40 💬 |
Allograft rejection 16件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis |
049 2件: 49, 53 💬 |
311 |
Itolizumab |
Itolizumab |
- |
- |
- |
049 1件: 49 💬 |
312 |
Itolizumab [bmab 600] |
Itolizumab |
- |
- |
- |
049 1件: 49 💬 |
313 |
Jbt-101 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 299 💬 |
314 |
Jnj-55920839 |
- |
- |
- |
- |
049 1件: 49 💬 |
315 |
Jnj-56022473 |
- |
- |
- |
- |
049 1件: 49 💬 |
316 |
Kineret |
- |
- |
- |
- |
028 9件: 28, 41, 46, 49, 65, 106, 107, 266, 299 💬 |
317 |
Kpg-818 |
- |
- |
- |
- |
049 1件: 49 💬 |
318 |
Kzr-616 |
KZR-616 |
- |
- |
- |
049 3件: 49, 50, 61 💬 |
319 |
L04aa26 |
- |
- |
- |
- |
049 1件: 49 💬 |
320 |
La294 |
- |
- |
- |
- |
049 1件: 49 💬 |
321 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 4件: 8 , 13, 49, 96 💬 |
322 |
Leflunomide |
Leflunomide |
1件: D00749 D00749 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
323 |
Lenalidomide |
Lenalidomide |
1件: D04687 D04687 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 7件: 16, 26, 28, 34, 49, 284, 300 💬 |
324 |
Levothyroxine |
Levothyroxine |
2件: D01010 D01010, D08125 D08125 💬 |
THRA 2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
049 2件: 49, 78 💬 |
325 |
Lisinopril |
Lisinopril |
2件: D00362 D00362, D08131 D08131 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 49, 66, 67, 113, 222 💬 |
326 |
Lisinopril pills |
Lisinopril |
2件: D00362 D00362, D08131 D08131 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 1件: 49 💬 |
327 |
Ljp 394 |
- |
- |
- |
- |
049 1件: 49 💬 |
328 |
Ljp394 |
- |
- |
- |
- |
049 1件: 49 💬 |
329 |
Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) |
Acetate |
11件: D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 3件: ESR1, ESR2, PGR 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 2件: 46, 49 💬 |
330 |
Low dietary sodium |
- |
- |
- |
- |
049 1件: 49 💬 |
331 |
Low dose mesenchymal stem cells (mscs) |
- |
- |
- |
- |
049 1件: 49 💬 |
332 |
Low-dose aldesleukin (proleukin®) |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 1件: 49 💬 |
333 |
Lulizumab pegol |
Lulizumab pegol |
- |
- |
- |
049 1件: 49 💬 |
334 |
Lupuzor |
- |
- |
- |
- |
049 1件: 49 💬 |
335 |
Ly2127399 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
336 |
Ly3009104 |
- |
- |
- |
- |
046 6件: 46, 49, 50, 93, 107, 325 💬 |
337 |
Ly3361237 |
- |
- |
- |
- |
049 1件: 49 💬 |
338 |
Ly3471851 |
- |
- |
- |
- |
049 1件: 49 💬 |
339 |
Lymphostat-b |
- |
- |
- |
- |
049 1件: 49 💬 |
340 |
Lymphostat-b tm |
- |
- |
- |
- |
049 1件: 49 💬 |
341 |
Lymphostat-b®, monoclonal anti-blys, lsb, benlysta® |
- |
- |
- |
- |
049 1件: 49 💬 |
342 |
M2951 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
343 |
M2951 (other name: evobrutinib) |
Evobrutinib |
- |
- |
- |
049 1件: 49 💬 |
344 |
M5049 |
- |
- |
- |
- |
049 1件: 49 💬 |
345 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
346 |
Mabthera (rituximab) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 4件: 13, 46, 49, 53 💬 |
347 |
Medi 545 |
- |
- |
- |
- |
049 1件: 49 💬 |
348 |
Medi-545 |
- |
- |
- |
- |
049 2件: 49, 50 💬 |
349 |
Medi-545 600 |
- |
- |
- |
- |
049 1件: 49 💬 |
350 |
Medi-546 |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
351 |
Medi-570 0.03 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
352 |
Medi-570 0.1 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
353 |
Medi-570 0.3 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
354 |
Medi-570 1 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
355 |
Medroxyprogesterone |
- |
- |
- |
- |
049 1件: 49 💬 |
356 |
Melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
357 |
Meloxicam |
Meloxicam |
1件: D00969 D00969 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 4件: 46, 49, 271, 296 💬 |
358 |
Memantine |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
359 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 11件: 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
360 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 9件: 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
361 |
Mesna |
- |
- |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
362 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
363 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
364 |
Methotrexate and folic acid |
Folic acid |
3件: D00070 D00070, D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
049 1件: 49 💬 |
365 |
Methyl prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
043 3件: 43, 49, 96 💬 |
366 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
367 |
Methylprednisolone sodium succinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 6件: 13, 46, 49, 50, 51, 211 💬 |
368 |
Micofenolico acido |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 1件: 49 💬 |
369 |
Milatuzumab |
Milatuzumab |
1件: D08944 D08944 💬 |
CD74 1件: CD74 💬 |
Antigen processing and presentation 3件: Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis |
049 1件: 49 💬 |
370 |
Milnacipran |
Milnacipran |
1件: D08222 D08222 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
046 2件: 46, 49 💬 |
371 |
Mizoribine |
Mizoribine |
1件: D01392 D01392 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬 |
372 |
Mmf |
- |
- |
- |
- |
013 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
373 |
Modafinil |
Modafinil |
1件: D01832 D01832 💬 |
- |
- |
006 4件: 6 , 13, 49, 93 💬 |
374 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
375 |
Moxifloxacin |
Moxifloxacin |
2件: D00874 D00874, D08237 D08237 💬 |
- |
- |
002 8件: 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
376 |
Mpa |
- |
- |
- |
- |
049 3件: 49, 51, 60 💬 |
377 |
Mra 003 us |
- |
- |
- |
- |
049 1件: 49 💬 |
378 |
Msc treatment |
- |
- |
- |
- |
049 1件: 49 💬 |
379 |
Msc2364447c |
- |
- |
- |
- |
013 2件: 13, 49 💬 |
380 |
Mt-1303 high dose |
- |
- |
- |
- |
049 1件: 49 💬 |
381 |
Mt-1303 low dose |
- |
- |
- |
- |
049 1件: 49 💬 |
382 |
Mtx |
- |
- |
- |
- |
035 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
383 |
Multivitamin |
- |
- |
- |
- |
049 1件: 49 💬 |
384 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
385 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
386 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 7件: 13, 49, 51, 60, 65, 66, 222 💬 |
387 |
Mycophenolate motetil |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 1件: 49 💬 |
388 |
Mycophenolic acid |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 8件: 11, 43, 49, 51, 60, 66, 96, 222 💬 |
389 |
Myfortic |
- |
- |
- |
- |
049 5件: 49, 66, 162, 222, 228 💬 |
390 |
Myfortic*50cpr riv 360mg |
- |
- |
- |
- |
049 1件: 49 💬 |
391 |
N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
- |
- |
- |
- |
049 1件: 49 💬 |
392 |
N-acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 10件: 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
393 |
Nelfinavir |
Nelfinavir |
2件: D00899 D00899, D08259 D08259 💬 |
- |
- |
049 3件: 49, 265, 331 💬 |
394 |
Nicotinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 6件: 2 , 6 , 18, 49, 162, 191 💬 |
395 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
396 |
Nnc 0151-0000-0000 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
397 |
Nnc0114-0006 |
- |
- |
- |
- |
046 3件: 46, 49, 96 💬 |
398 |
Norethindrone |
Norethisterone |
2件: D00182 D00182, D00953 D00953 💬 |
PGR 1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 4件: 13, 46, 49, 299 💬 |
399 |
Normal saline |
- |
- |
- |
- |
006 16件: 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
400 |
Nox-e36 |
- |
- |
- |
- |
049 1件: 49 💬 |
401 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
402 |
Ocrelizumab |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 3件: 13, 46, 49 💬 |
403 |
Olive |
Olea europaea leaf |
- |
- |
- |
013 3件: 13, 49, 53 💬 |
404 |
Olive oil |
Olea europaea leaf |
1件: D03311 D03311 💬 |
- |
- |
013 3件: 13, 49, 53 💬 |
405 |
Olumiant |
- |
- |
- |
- |
046 4件: 46, 49, 93, 107 💬 |
406 |
Omacor |
- |
- |
- |
- |
049 1件: 49 💬 |
407 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 7件: 13, 46, 49, 66, 79, 96, 299 💬 |
408 |
Oral prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 2件: 49, 145 💬 |
409 |
Oral prednisone 5mg |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
410 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
411 |
Orencia 125 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 3件: 46, 49, 53 💬 |
412 |
Ortho-novum |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
413 |
Ortho-novum 777 |
- |
- |
- |
- |
049 1件: 49 💬 |
414 |
Other: blood drawing only group c |
- |
- |
- |
- |
049 1件: 49 💬 |
415 |
Other: coaching sessions |
- |
- |
- |
- |
049 1件: 49 💬 |
416 |
Other: concomitant medication |
- |
- |
- |
- |
049 1件: 49 💬 |
417 |
Other: corn starch |
Starch, corn |
1件: D05297 D05297 💬 |
- |
- |
049 1件: 49 💬 |
418 |
Other: drug free |
- |
- |
- |
- |
049 1件: 49 💬 |
419 |
Other: fitbit activity monitor |
Methamidophos |
- |
- |
- |
049 1件: 49 💬 |
420 |
Other: group b sle one blood donation |
- |
- |
- |
- |
049 1件: 49 💬 |
421 |
Other: gsk2586184 single dose taken with food |
- |
- |
- |
- |
049 1件: 49 💬 |
422 |
Other: gsk2586184 single dose taken without food |
- |
- |
- |
- |
049 1件: 49 💬 |
423 |
Other: immunologic technique |
- |
- |
- |
- |
049 1件: 49 💬 |
424 |
Other: isa 51 vg |
- |
- |
- |
- |
049 1件: 49 💬 |
425 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
426 |
Other: pharmacokinetic analysis |
- |
- |
- |
- |
049 1件: 49 💬 |
427 |
Other: sle treatment |
- |
- |
- |
- |
049 1件: 49 💬 |
428 |
Other: smartphone application |
- |
- |
- |
- |
049 1件: 49 💬 |
429 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
430 |
Other: standard therapy |
- |
- |
- |
- |
049 1件: 49 💬 |
431 |
Other: standard treatment according to the clinical protocols |
- |
- |
- |
- |
049 1件: 49 💬 |
432 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 1件: 49 💬 |
433 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
434 |
Ozone |
Ozone |
- |
- |
- |
049 2件: 49, 51 💬 |
435 |
P 140 |
- |
- |
- |
- |
049 1件: 49 💬 |
436 |
Pah |
- |
- |
- |
- |
049 3件: 49, 53, 86 💬 |
437 |
Paquinimod |
Paquinimod |
- |
- |
- |
049 2件: 49, 51 💬 |
438 |
Paquinimod (abr-215757) |
Paquinimod |
- |
- |
- |
049 1件: 49 💬 |
439 |
Pf-04236921 |
- |
- |
- |
- |
049 2件: 49, 96 💬 |
440 |
Pf-06700841 |
PF-06700841 |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
441 |
Pf-06700841 15 mg |
PF-06700841 |
- |
- |
- |
049 1件: 49 💬 |
442 |
Pf-06700841 25mg |
PF-06700841 |
- |
- |
- |
049 1件: 49 💬 |
443 |
Pf-06700841 30 mg |
PF-06700841 |
- |
- |
- |
049 1件: 49 💬 |
444 |
Pf-06700841 45 mg |
PF-06700841 |
- |
- |
- |
049 1件: 49 💬 |
445 |
Pf-06700841 5mg |
PF-06700841 |
- |
- |
- |
049 1件: 49 💬 |
446 |
Pf-06700841-15 |
PF-06700841 |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
447 |
Pf-06835375 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
448 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
449 |
Phosphate-buffered saline |
Phosphate ion |
- |
- |
- |
049 1件: 49 💬 |
450 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
451 |
Pitavastatin |
Pitavastatin |
1件: D01862 D01862 💬 |
- |
- |
049 1件: 49 💬 |
452 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
453 |
Plaquenil |
- |
- |
- |
- |
046 4件: 46, 49, 53, 96 💬 |
454 |
Pneumovax |
- |
- |
- |
- |
046 3件: 46, 49, 96 💬 |
455 |
Pooled mesenchymal stem cell |
- |
- |
- |
- |
049 1件: 49 💬 |
456 |
Prasterone |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 1件: 49 💬 |
457 |
Prasterone (gl701) |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 1件: 49 💬 |
458 |
Pravastatin |
Pravastatin |
2件: D00893 D00893, D08410 D08410 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
459 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
460 |
Prednisolone/prednisone |
Prednisolone |
9件: D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
461 |
Prednisona |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 3件: 46, 49, 222 💬 |
462 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
463 |
Prednisone acetate |
Acetate |
2件: D00473 D00473, D08416 D08416 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
040 3件: 40, 49, 224 💬 |
464 |
Prednisone discontinuation |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
465 |
Premarin and provera |
- |
- |
- |
- |
049 1件: 49 💬 |
466 |
Prevenar® and pneumo23® |
- |
- |
- |
- |
049 1件: 49 💬 |
467 |
Procedure: autologous cd34+hpc transplantation (hsct) |
- |
- |
- |
- |
049 1件: 49 💬 |
468 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 6件: 11, 13, 14, 28, 49, 51 💬 |
469 |
Procedure: autologous peripheral blood stem cell transplantation |
- |
- |
- |
- |
028 8件: 28, 40, 41, 42, 45, 46, 49, 283 💬 |
470 |
Procedure: cd34+ peripheral blood stem cell reinfusion |
- |
- |
- |
- |
049 1件: 49 💬 |
471 |
Procedure: computed tomography |
- |
- |
- |
- |
034 5件: 34, 40, 46, 49, 96 💬 |
472 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 5件: 49, 51, 96, 284, 285 💬 |
473 |
Procedure: mri, venipuncture |
- |
- |
- |
- |
049 1件: 49 💬 |
474 |
Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) |
- |
- |
- |
- |
049 1件: 49 💬 |
475 |
Procedure: plasmapheresis |
- |
- |
- |
- |
011 3件: 11, 49, 222 💬 |
476 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 4件: 40, 46, 49, 96 💬 |
477 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
478 |
Proleukin |
- |
- |
- |
- |
002 3件: 2 , 49, 65 💬 |
479 |
Quinipril |
- |
- |
- |
- |
049 1件: 49 💬 |
480 |
R-salbutamol |
Levosalbutamol |
2件: D02147 D02147, D08124 D08124 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
481 |
R-salbutamol sulphate |
Levosalbutamol |
2件: D02147 D02147, D08124 D08124 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
482 |
R932333 |
- |
- |
- |
- |
049 1件: 49 💬 |
483 |
Rabbit |
Rabbit |
- |
- |
- |
011 8件: 11, 13, 49, 51, 60, 65, 96, 285 💬 |
484 |
Rabbit anti-thymocyte globulin |
Rabbit |
- |
- |
- |
049 2件: 49, 65 💬 |
485 |
Rabbit antithymocyte globulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
049 3件: 49, 60, 96 💬 |
486 |
Radiation: fluorine f 18 clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
040 4件: 40, 46, 49, 96 💬 |
487 |
Radiation: total body irradiation |
- |
- |
- |
- |
036 7件: 36, 49, 51, 60, 65, 283, 284 💬 |
488 |
Ramipril |
Ramipril |
1件: D00421 D00421 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 7件: 46, 49, 66, 67, 113, 218, 257 💬 |
489 |
Rankl/opg ratio |
- |
- |
- |
- |
049 1件: 49 💬 |
490 |
Rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 18件: 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
491 |
Raptiva |
- |
- |
- |
- |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
492 |
Rayos |
- |
- |
- |
- |
049 1件: 49 💬 |
493 |
Rc18 160 mg plus standard therapy |
- |
- |
- |
- |
049 1件: 49 💬 |
494 |
Rc18 240 mg plus standard therapy |
- |
- |
- |
- |
049 1件: 49 💬 |
495 |
Rc18 80 mg plus standard therapy |
- |
- |
- |
- |
049 1件: 49 💬 |
496 |
Recombinant factor fc fusion protein |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
497 |
Recombinant zoster vaccine |
- |
- |
- |
- |
049 1件: 49 💬 |
498 |
Remicade |
- |
- |
- |
- |
040 9件: 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
499 |
Rhumab 2h7 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
500 |
Rhumab ifnalpha |
- |
- |
- |
- |
049 1件: 49 💬 |
501 |
Rigerimod |
- |
- |
- |
- |
049 1件: 49 💬 |
502 |
Riquent |
- |
- |
- |
- |
049 1件: 49 💬 |
503 |
Rituxan (rituximab) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
049 1件: 49 💬 |
504 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
505 |
Rivaroxaban |
Rivaroxaban |
1件: D07086 D07086 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 5件: 46, 49, 75, 91, 210 💬 |
506 |
Ro 106-1443 |
- |
- |
- |
- |
049 1件: 49 💬 |
507 |
Ro 496-4913 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
508 |
Ro7010939/f13 |
- |
- |
- |
- |
049 1件: 49 💬 |
509 |
Rontalizumab |
Rontalizumab |
1件: D09662 D09662 💬 |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease 23件: Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 1件: 49 💬 |
510 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
511 |
Rosuvastatin calcium |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 4件: 49, 79, 97, 299 💬 |
512 |
Royal jelly |
Royal jelly |
1件: D09754 D09754 💬 |
- |
- |
049 1件: 49 💬 |
513 |
Rslv-132 |
- |
- |
- |
- |
049 2件: 49, 53 💬 |
514 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
515 |
Sar113244 |
- |
- |
- |
- |
049 1件: 49 💬 |
516 |
Sbi-087 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
517 |
Sc belimumab 200 mg |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
518 |
Sifalimumab |
Sifalimumab |
1件: D09668 D09668 💬 |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease 23件: Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 1件: 49 💬 |
519 |
Sifalimumab 1,200 mg |
Sifalimumab |
1件: D09668 D09668 💬 |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease 23件: Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 1件: 49 💬 |
520 |
Sifalimumab 200 mg |
Sifalimumab |
1件: D09668 D09668 💬 |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease 23件: Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 1件: 49 💬 |
521 |
Sifalimumab 600 mg |
Sifalimumab |
1件: D09668 D09668 💬 |
IFNA1 13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease 23件: Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 1件: 49 💬 |
522 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
523 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
524 |
Sm101 |
- |
- |
- |
- |
049 3件: 49, 63, 66 💬 |
525 |
Sm934 |
- |
- |
- |
- |
049 1件: 49 💬 |
526 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
527 |
Soluble fc receptor |
- |
- |
- |
- |
049 1件: 49 💬 |
528 |
Soluble fc-gamma receptor iib |
- |
- |
- |
- |
049 1件: 49 💬 |
529 |
Sq fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
049 1件: 49 💬 |
530 |
Standard dose of rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
049 1件: 49 💬 |
531 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
532 |
Standard therapy |
- |
- |
- |
- |
049 2件: 49, 97 💬 |
533 |
Standard therapy (excluding immunosuppressants) |
- |
- |
- |
- |
049 1件: 49 💬 |
534 |
Standard therapy (including immunosuppressants) |
- |
- |
- |
- |
049 1件: 49 💬 |
535 |
Stelara |
- |
- |
- |
- |
049 6件: 49, 56, 96, 97, 269, 271 💬 |
536 |
Stelara® |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
537 |
Steroid drug |
- |
- |
- |
- |
049 1件: 49 💬 |
538 |
Steroid taper |
- |
- |
- |
- |
049 1件: 49 💬 |
539 |
Subcuvia |
- |
- |
- |
- |
014 3件: 14, 49, 65 💬 |
540 |
Sugar pill |
- |
- |
- |
- |
005 8件: 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
541 |
Sulfamethoxazole |
Sulfamethoxazole |
1件: D00447 D00447 💬 |
- |
- |
044 4件: 44, 49, 85, 299 💬 |
542 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
543 |
Switch to myfortic |
- |
- |
- |
- |
049 1件: 49 💬 |
544 |
Tab08 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
545 |
Tabalumab |
Tabalumab |
1件: D10083 D10083 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 2件: 46, 49 💬 |
546 |
Tabalumab auto-injector |
Tabalumab |
1件: D10083 D10083 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 2件: 46, 49 💬 |
547 |
Tabalumab prefilled syringe |
Tabalumab |
1件: D10083 D10083 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 2件: 46, 49 💬 |
548 |
Taci-fc5 |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 46, 49 💬 |
549 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
550 |
Tak-079 |
- |
- |
- |
- |
011 3件: 11, 49, 63 💬 |
551 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
552 |
The generic name is warfarin and many producers will be involved |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 1件: 49 💬 |
553 |
Tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 5件: 13, 49, 206, 257, 298 💬 |
554 |
Tocopherol acetate |
Acetate |
1件: D02332 D02332 💬 |
- |
- |
049 1件: 49 💬 |
555 |
Toctino |
- |
- |
- |
- |
049 1件: 49 💬 |
556 |
Toctino® |
- |
- |
- |
- |
049 1件: 49 💬 |
557 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
558 |
Tofacitinib citrate |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 5件: 46, 49, 97, 107, 271 💬 |
559 |
Trade name xarelto |
- |
- |
- |
- |
049 1件: 49 💬 |
560 |
Trimethoprim |
Trimethoprim |
2件: D00145 D00145, D06236 D06236 💬 |
- |
- |
036 6件: 36, 44, 49, 60, 85, 299 💬 |
561 |
Trimethoprim-sulfamethoxazole |
Sulfamethoxazole |
3件: D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
049 2件: 49, 299 💬 |
562 |
Triptorelin |
Triptorelin |
1件: D06247 D06247 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
049 2件: 49, 76 💬 |
563 |
Triptorelin pamoate |
Triptorelin |
1件: D06247 D06247 💬 |
GNRHR 1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
564 |
Tru-015 |
TRU-015 |
- |
- |
- |
046 3件: 46, 49, 222 💬 |
565 |
Truxima |
- |
- |
- |
- |
049 2件: 49, 222 💬 |
566 |
Tv-4710 |
- |
- |
- |
- |
049 1件: 49 💬 |
567 |
Upadacitinib |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 7件: 40, 41, 46, 49, 96, 97, 271 💬 |
568 |
Urine sample |
- |
- |
- |
- |
049 3件: 49, 51, 61 💬 |
569 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
570 |
Ustekinumab (approximately 6 mg/kg) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 1件: 49 💬 |
571 |
Ustekinumab 90 mg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 4件: 49, 50, 93, 96 💬 |
572 |
Ustekinumab 90 milligram (mg) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 1件: 49 💬 |
573 |
Ustekinumab iv |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 2件: 49, 97 💬 |
574 |
Ustekinumab sc |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 2件: 49, 97 💬 |
575 |
Vaccination |
- |
- |
- |
- |
049 1件: 49 💬 |
576 |
Vaccine |
- |
- |
- |
- |
049 1件: 49 💬 |
577 |
Vay736 |
- |
- |
- |
- |
013 7件: 13, 35, 46, 49, 53, 85, 95 💬 |
578 |
Velcade |
- |
- |
- |
- |
011 5件: 11, 28, 46, 49, 61 💬 |
579 |
Velcade® |
- |
- |
- |
- |
011 3件: 11, 46, 49 💬 |
580 |
Versus hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
581 |
Vib7734 |
- |
- |
- |
- |
049 4件: 49, 50, 51, 53 💬 |
582 |
Vip |
- |
- |
- |
- |
049 3件: 49, 51, 86 💬 |
583 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
584 |
Vitamin d 25(oh)d |
Vitamin D |
- |
- |
- |
049 1件: 49 💬 |
585 |
Vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 11件: 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
586 |
Vitamin d3 400 iu |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 1件: 49 💬 |
587 |
Vitamin d3 6000 iu |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 1件: 49 💬 |
588 |
Vitamins: b6, b12, and folate |
Folic acid |
1件: D00070 D00070 💬 |
- |
- |
049 1件: 49 💬 |
589 |
Vobarilizumab |
Vobarilizumab |
1件: D11005 D11005 💬 |
- |
- |
049 1件: 49 💬 |
590 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
591 |
Warfarin sodium |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 1件: 49 💬 |
592 |
Xarelto |
- |
- |
- |
- |
049 2件: 49, 210 💬 |
593 |
Xmab5871 |
- |
- |
- |
- |
049 2件: 49, 300 💬 |
594 |
Zishenqing |
- |
- |
- |
- |
049 1件: 49 💬 |
595 |
Zostavax |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
596 |
Zostavax vaccine |
- |
- |
- |
- |
046 2件: 46, 49 💬 |